Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Blue Sky MD vs Found

Blue Sky MD
Graded #169

Lower grade

vs+16
Found
Graded #14

Higher grade

The verdict

Found takes it — 83.5/100 to 67.5/100.

Found grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The broadest medication bench on the board — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFound +14
64
78
Dose & formulationFound +30
64
94
Clinical oversightBlue Sky MD +1
87
86
Labs & monitoringFound +20
62
82
FulfillmentFound +21
63
84
Contract termsFound +15
55
70
Blue Sky MD · left barFound · right bar

The numbers

MetricBlue Sky MDFound
WeighScore67.5/10083.5/100
GradeCB
Scorecard rank#169#14
Semaglutide$160/mo (starting dose, compounded)Compounded from $99/mo
Tirzepatide$240/mo (starting dose, compounded)Compounded from $99/mo
Coverage1 statesAll 50 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Blue Sky MD

Graded #169 · C

Strengths

  • LegitScript certified and physician-led since 2008; one of the most established GLP-1 practices in the Southeast
  • Compounded semaglutide from $40/week (~$160/month) and tirzepatide from $60/week (~$240/month) — well below brand-name cost
  • Comprehensive program includes 1-on-1 wellness coaching, nutrition plans, hormone analysis, and a proprietary mobile app
  • Medication shipped directly to patients’ homes within 3–5 business days; telehealth visits available
  • Insurance accepted in many cases; affordable self-pay options for uninsured patients

Where it loses points

  • Geographic reach unclear — physical clinics in NC only; telehealth states beyond NC unconfirmed despite 'from virtually anywhere' claim
  • Pricing quoted per-week ($40 sema / $60 tirz) rather than per-month; higher-dose pricing not disclosed
  • Must enroll in full medical weight-loss program to access GLP-1 medications — medication-only Rx not offered
  • No explicit lab testing protocol published; online FAQ does not confirm labs are included
  • Small regional provider vs. national platforms; limited provider footprint outside North Carolina
Found

Graded #14 · B

Strengths

  • Widest medication list on this board — compounded semaglutide and tirzepatide, brand Wegovy, Zepbound, Ozempic, Mounjaro, Saxenda and Victoza, plus oral Foundayo (orforglipron) and Rybelsus
  • Flat pricing as the dose increases, so a titration does not raise the monthly cost
  • Bills insurance for the clinical visits — the site states most members pay under $30 per visit
  • Runs a dedicated GLP-1 microdose programme for people who want a lower starting dose

Where it loses points

  • The $99/mo headline is a longer-plan floor — Found's own FAQ says 3, 6 and 12-month plans are what keep the monthly cost down, so month-to-month costs meaningfully more
  • Medication cost is separate from the membership and clinical care, so no advertised figure is the all-in number
  • The homepage insurance selector lists roughly 41 states, not 50 — coverage is narrower than the service footprint
  • Compounded medication is not FDA-approved the way brand Wegovy or Zepbound are

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard